1. AB0990 Rituximab in Chronic Autoimmune Rheumatic Diseases: Safety and Clinical Profile after 12 and 24 Months of Follow-Up. (15th July 2016) Authors: Mata Martínez, C.; Garcia-Montoya, L.; Ovalles-Bonilla, J.G.; Nieto, J.C.; Lόpez-Longo, F.J.; Valor, L.; Serrano, B.; González, R.D.; Saenz, C.N.; Correyero, M.; Janta, I.; Martínez Barrio, J.; Naredo, E.; González, C.; Hernandez, D.; Monteagudo, I. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0318 Antisynthetase Syndrome: Clinical and Serological Characteristics at Disease Onset. (10th June 2014) Authors: Martínez-Barrio, J.; Hinojosa, M.; Lopez-Longo, J.; Ovalles-Bonilla, J.G.; Bello, N.; Mata Martínez, C.; Serrano, B.; Nieto Gonzalez, J.C.; Martínez Estupiñan, L.; Gonzalez, C.; Montoro, M.; Valor, L.; Monteagudo, I.; Naredo, E.; Carreño, L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗